Drosophila Models of Sporadic Parkinson's Disease
- PMID: 30373150
- PMCID: PMC6275057
- DOI: 10.3390/ijms19113343
Drosophila Models of Sporadic Parkinson's Disease
Abstract
Parkinson's disease (PD) is the most common cause of movement disorders and is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. It is increasingly recognized as a complex group of disorders presenting widely heterogeneous symptoms and pathology. With the exception of the rare monogenic forms, the majority of PD cases result from an interaction between multiple genetic and environmental risk factors. The search for these risk factors and the development of preclinical animal models are in progress, aiming to provide mechanistic insights into the pathogenesis of PD. This review summarizes the studies that capitalize on modeling sporadic (i.e., nonfamilial) PD using Drosophila melanogaster and discusses their methodologies, new findings, and future perspectives.
Keywords: Drosophila; animal model; sporadic Parkinson’s disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease.Brain Res. 2014 Oct 2;1583:277-86. doi: 10.1016/j.brainres.2014.08.021. Epub 2014 Aug 15. Brain Res. 2014. PMID: 25130663
-
Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.J Neurochem. 2014 Nov;131(3):369-82. doi: 10.1111/jnc.12818. Epub 2014 Jul 31. J Neurochem. 2014. PMID: 25040725
-
Drosophila models of Parkinson's disease.Adv Genet. 2011;73:1-50. doi: 10.1016/B978-0-12-380860-8.00001-X. Adv Genet. 2011. PMID: 21310293 Review.
-
Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.Regen Med. 2007 Jul;2(4):447-55. doi: 10.2217/17460751.2.4.447. Regen Med. 2007. PMID: 17635051
-
Pathogenesis and animal studies of Parkinson's disease.Curr Opin Neurol Neurosurg. 1993 Jun;6(3):323-32. Curr Opin Neurol Neurosurg. 1993. PMID: 8507901 Review.
Cited by
-
Towards improved screening of toxins for Parkinson's risk.NPJ Parkinsons Dis. 2023 Dec 19;9(1):169. doi: 10.1038/s41531-023-00615-9. NPJ Parkinsons Dis. 2023. PMID: 38114496 Free PMC article. Review.
-
Maintenance of mitochondrial integrity in midbrain dopaminergic neurons governed by a conserved developmental transcription factor.Nat Commun. 2022 Mar 17;13(1):1426. doi: 10.1038/s41467-022-29075-0. Nat Commun. 2022. PMID: 35301315 Free PMC article.
-
A new model for fatty acid hydroxylase-associated neurodegeneration reveals mitochondrial and autophagy abnormalities.Front Cell Dev Biol. 2022 Dec 14;10:1000553. doi: 10.3389/fcell.2022.1000553. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36589738 Free PMC article.
-
Lamp1 Deficiency Enhances Sensitivity to α-Synuclein and Oxidative Stress in Drosophila Models of Parkinson Disease.Int J Mol Sci. 2022 Oct 28;23(21):13078. doi: 10.3390/ijms232113078. Int J Mol Sci. 2022. PMID: 36361864 Free PMC article.
-
A new metabolic model of Drosophila melanogaster and the integrative analysis of Parkinson's disease.Life Sci Alliance. 2023 May 26;6(8):e202201695. doi: 10.26508/lsa.202201695. Print 2023 Aug. Life Sci Alliance. 2023. PMID: 37236669 Free PMC article.
References
-
- Kalia L.V., Lang A.E., Hazrati L.N., Fujioka S., Wszolek Z.K., Dickson D.W., Ross O.A., Van Deerlin V.M., Trojanowski J.Q., Hurtig H.I., et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015;72:100–105. doi: 10.1001/jamaneurol.2014.2704. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases